Lifelong Biological Private Limited - Due diligence report

A 360° intelligence report on Lifelong Biological Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2007-08-22 Bangalore South, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
LB Lifelong Biological Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Lifelong Biological Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Lifelong Biological Private Limited is assessed as Low Risk with a Trust Score of 86/100. Lifelong Biological Private Limited is an active private limited indian non-government company incorporated in 2007, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 10 Aug 2026 from the latest processed filings. Lifelong Biological Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
BHAWARLAL 01234567 Director 01/04/2018 6 yrs Approved
SONU DANTEWADIA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Trigenesis Lifesciences Private Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Trigenesis Lifesciences Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 65
Growth signals & trust indicators
Operating for 18+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 10 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Sep 2023
Director ceased
BHAWARLAL
29 Dec 2022
Director appointed
BHAWARLAL (Director)
31 Dec 2020
Director ceased
VIJAY NAHAR
16 Dec 2019
Director ceased
VINOD NAHAR
27 Sep 2017
Director ceased
SONU DANTEWADIA
30 Aug 2017
Director appointed
SONU DANTEWADIA (Director)
Director ceased
GOPAL SARDA
22 Aug 2007
Incorporated
Registered with Roc Bangalore
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Natraj Chemicals Private Limited U00304BR2000PTC009259 Patna- 800 008, Bihar, India
New Raj Darbar Herbal Medicine Private Limited U74999JH2016PTC009154 Dumka, Jharkhand, India
Vnb Pharma Private Limited U51397GJ2020PTC114039 Ahmedabad, Gujarat, India
Murbad Glass Private Limited U26102MH1990PTC056399 Mumbai, Maharashtra, India
Hva Chemical Solution Private Limited U24119TN2018PTC123455 Paramakudi, Tamil Nadu, India
Sanil Pharmaceuticals Private Limited U24239KA1989PTC010426 Bengaluru, Karnataka, India
Moon Industries Limited U00000DL1993PLC055446 New Delhi, Delhi, India
Lrc Speciality Surfactants Private Limited U24100UR2010PTC033306 Roorkee, Uttarakhand, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Lifelong Biological Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Lifelong Biological Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Lifelong Biological Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Lifelong Biological Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Lifelong Biological Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Lifelong Biological Private Limited an active company?

Lifelong Biological Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Lifelong Biological Private Limited financially healthy?

Lifelong Biological Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Lifelong Biological Private Limited?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Lifelong Biological Private Limited?

The ultimate holding entity is Trigenesis Lifesciences Private Limited. 2 active director(s) are on record.

Does Lifelong Biological Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Lifelong Biological Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Lifelong Biological Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.